Thomas E. Mahan

6.1k total citations · 4 hit papers
27 papers, 4.2k citations indexed

About

Thomas E. Mahan is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Thomas E. Mahan has authored 27 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 14 papers in Neurology and 6 papers in Molecular Biology. Recurrent topics in Thomas E. Mahan's work include Alzheimer's disease research and treatments (19 papers), Neuroinflammation and Neurodegeneration Mechanisms (14 papers) and Sleep and Wakefulness Research (6 papers). Thomas E. Mahan is often cited by papers focused on Alzheimer's disease research and treatments (19 papers), Neuroinflammation and Neurodegeneration Mechanisms (14 papers) and Sleep and Wakefulness Research (6 papers). Thomas E. Mahan collaborates with scholars based in United States, Germany and Japan. Thomas E. Mahan's co-authors include David M. Holtzman, John R. Cirrito, Jason D. Ulrich, Marc I. Diamond, Floy R. Stewart, Mary Beth Finn, Jerrah K. Holth, Hong Jiang, Marco Colonna and David F. Wozniak and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Thomas E. Mahan

27 papers receiving 4.2k citations

Hit Papers

TREM2-mediated early microglial response limits diffusion... 2014 2026 2018 2022 2016 2019 2014 2014 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas E. Mahan United States 20 2.6k 1.8k 1.0k 941 646 27 4.2k
Mary Beth Finn United States 19 2.9k 1.1× 1.5k 0.8× 1.1k 1.1× 1.2k 1.3× 873 1.4× 23 5.1k
Floy R. Stewart United States 19 3.5k 1.4× 1.6k 0.9× 1.4k 1.4× 1.2k 1.3× 1.1k 1.7× 24 5.3k
Christopher M. Norris United States 35 1.4k 0.5× 1.5k 0.8× 1.8k 1.7× 1.5k 1.6× 590 0.9× 96 4.0k
Melissa Manis United States 12 945 0.4× 1.1k 0.6× 401 0.4× 415 0.4× 297 0.5× 16 2.1k
Diederik Moechars Belgium 28 1.9k 0.7× 930 0.5× 1.1k 1.1× 1.3k 1.3× 311 0.5× 53 3.8k
Tina L. Beckett United States 30 1.6k 0.6× 718 0.4× 563 0.6× 999 1.1× 242 0.4× 58 2.8k
Michiko Narita Japan 38 1.7k 0.7× 345 0.2× 1.9k 1.9× 1.1k 1.2× 726 1.1× 94 3.8k
Nada M. Porter United States 31 1.5k 0.6× 919 0.5× 1.3k 1.3× 1.9k 2.0× 364 0.6× 44 4.4k
Rena Li United States 23 1.5k 0.6× 809 0.4× 513 0.5× 744 0.8× 194 0.3× 60 2.8k
Luı́sa V. Lopes Portugal 31 604 0.2× 857 0.5× 1.3k 1.3× 865 0.9× 173 0.3× 65 3.3k

Countries citing papers authored by Thomas E. Mahan

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Mahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Mahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Mahan more than expected).

Fields of papers citing papers by Thomas E. Mahan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Mahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Mahan. The network helps show where Thomas E. Mahan may publish in the future.

Co-authorship network of co-authors of Thomas E. Mahan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Mahan. A scholar is included among the top collaborators of Thomas E. Mahan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Mahan. Thomas E. Mahan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahan, Thomas E., et al.. (2022). Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis. Molecular Neurodegeneration. 17(1). 13–13. 78 indexed citations
2.
Lall, Deepti, Ileana Lorenzini, Shaughn Bell, et al.. (2021). C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation. Neuron. 109(14). 2275–2291.e8. 83 indexed citations
3.
Holth, Jerrah K., Sarah K. Fritschi, Chanung Wang, et al.. (2019). The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science. 363(6429). 880–884. 537 indexed citations breakdown →
4.
Huynh, Tien‐Phat V., Chao Wang, G. Travis Tabor, et al.. (2019). Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model. Molecular Neurodegeneration. 14(1). 37–37. 87 indexed citations
5.
Lessard, Christian, Yingyue Zhou, Thomas B. Ladd, et al.. (2018). High‐affinity interactions and signal transduction between Aβ oligomers and TREM 2. EMBO Molecular Medicine. 10(11). 104 indexed citations
6.
Huynh, Tien‐Phat V., Fan Liao, Caroline Massad Francis, et al.. (2017). Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosis. Neuron. 96(5). 1013–1023.e4. 144 indexed citations
7.
Wang, Yaming, Tyler K. Ulland, Jason D. Ulrich, et al.. (2016). TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. The Journal of Experimental Medicine. 213(5). 667–675. 571 indexed citations breakdown →
8.
Liao, Fan, Hong Jiang, Subhashini Srivatsan, et al.. (2015). Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse model. Molecular Neurodegeneration. 10(1). 12–12. 39 indexed citations
9.
Yamada, Kaoru, Tirth K. Patel, Katja Hochgräfe, et al.. (2015). Analysis of in vivo turnover of tau in a mouse model of tauopathy. Molecular Neurodegeneration. 10(1). 55–55. 57 indexed citations
10.
Liao, Fan, et al.. (2014). Effects of growth hormone–releasing hormone on sleep and brain interstitial fluid amyloid-β in an APP transgenic mouse model. Brain Behavior and Immunity. 47. 163–171. 18 indexed citations
11.
Yamada, Kaoru, Jerrah K. Holth, Fan Liao, et al.. (2014). Neuronal activity regulates extracellular tau in vivo. The Journal of Experimental Medicine. 211(3). 387–393. 422 indexed citations breakdown →
12.
Roh, Jee Hoon, Hong Jiang, Mary Beth Finn, et al.. (2014). Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease. The Journal of Experimental Medicine. 211(13). 2487–2496. 184 indexed citations
13.
Roh, Jee Hoon, Hong Jiang, Mary Beth Finn, et al.. (2014). Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease. The Journal of Experimental Medicine. 212(1). 121–121. 13 indexed citations
14.
Liao, Fan, Yukiko Hori, Eloïse Hudry, et al.. (2014). Anti-ApoE Antibody Given after Plaque Onset Decreases Aβ Accumulation and Improves Brain Function in a Mouse Model of Aβ Amyloidosis. Journal of Neuroscience. 34(21). 7281–7292. 95 indexed citations
15.
Ulrich, Jason D., Mary Beth Finn, Yaming Wang, et al.. (2014). Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2. Molecular Neurodegeneration. 9(1). 20–20. 239 indexed citations
16.
Holmes, Brandon B., Jennifer L. Furman, Thomas E. Mahan, et al.. (2014). Proteopathic tau seeding predicts tauopathy in vivo. Proceedings of the National Academy of Sciences. 111(41). E4376–85. 456 indexed citations breakdown →
17.
Yamada, Kaoru, Jerrah K. Holth, Fan Liao, et al.. (2014). Neuronal activity regulates extracellular tau in vivo. The Journal of General Physiology. 143(4). 1434OIA12–1434OIA12. 2 indexed citations
18.
Yanamandra, Kiran, Najla Kfoury, Hong Jiang, et al.. (2013). Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo. Neuron. 80(2). 402–414. 430 indexed citations
19.
Yanamandra, Kiran, Najla Kfoury, Thomas E. Mahan, et al.. (2013). Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo. Neuron. 80(6). 1572–1572. 8 indexed citations
20.
Ulrich, Jason D., Jessica L. Restivo, Dorothy R. Schuler, et al.. (2013). In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis. Molecular Neurodegeneration. 8(1). 13–13. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026